Tolerance of weekly metronomic paclitaxel and carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer patients who are unlikely to tolerate 3 weekly paclitaxel and carboplatin

Tolerance of weekly metronomic paclitaxel and carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer patients who are unlikely to tolerate 3 weekly paclitaxel and carboplatin

Bibliographic Details
Main Authors: Dessai, S. B., Chakraborty, S., Babu, T. V. S., Nayanar, S., Bhattacharjee, A., Jones, J., Balasubramanian, S., Patil, Vijay M.
Format: Online
Language:English
Published: Medknow Publications & Media Pvt Ltd 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873699/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873699/

Similar Items